# Beta Bionics, Inc. (BBNX): MoatMap facts

As of 24 Oct 2026. Research data, not investment advice.

As of 24 Oct 2026, MoatMap's StockRank for Beta Bionics, Inc. (BBNX) is 40/100, ranked against 24,000+ stocks in 35 markets (Quality 41, Value 29, Momentum 62, each scored against its sector).

- StockRank: 40/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 41, Value 29, Momentum 62: each a 0-100 percentile within Healthcare.
- Position: #16,156 overall, #1,396 in Healthcare.
- Listing: United States, NGM; Healthcare / Medical Devices.
- Last close: 20.51 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors sold USD 3.1M.

Source: https://moatmap.ai/stock/BBNX
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker